You are here

  • Home
  • Online First
  • Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group

Article metrics

Article menu

other Versions

Download PDFPDF
Original research
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group

 

Online download statistics by month:

Online download statistics by month: January 2022 to June 2023

AbstractFullPdf
Jan 20224883942
Feb 202210181410
Mar 202235265
Apr 202225056
May 202215463
Jun 2022486465106
Jul 202233331755
Aug 202216514836
Sep 2022978422
Oct 202213011625
Nov 2022734913
Dec 2022736123
Jan 2023474122
Feb 2023656024
Mar 202347368
Apr 2023332417
May 2023383311
Jun 2023100
Total38501504428